Clinical considerations for the management of cancer patients in the mitigation stage of the COVID-19 pandemic.
Am J Cancer Res
; 10(8): 2282-2292, 2020.
Article
in English
| MEDLINE | ID: covidwho-754989
ABSTRACT
The ongoing outbreak of the coronavirus disease 2019 (COVID-19) has become an unprecedented threat to public health around the world. The crisis has also brought great challenges to the routine diagnosis and treatment of cancer patients, especially given the urgency and continuity of cancer care. Cancer patients need to be more prudently and individually managed to combat COVID-19. At present, the COVID-19 epidemic in some countries has moved from the outbreak phase to the remission phase. How to preserve high-quality anti-tumor therapy for cancer patients while maintaining strict prevention and control of COVID-19 is a matter of concern. Here, we summarized essential data about COVID-19 and cancer and provided the clinical recommendations for the management of cancer patients during the COVID-19 pandemic based on our practical experience and relevant literatures.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Prognostic study
Language:
English
Journal:
Am J Cancer Res
Year:
2020
Document Type:
Article
Affiliation country:
China
Similar
MEDLINE
...
LILACS
LIS